Results 41 to 50 of about 709,899 (268)

Genome profiling of mismatch repair genes in eight types of tumors. [PDF]

Cell Cycle, 2021
Wang S, Guan G, Zou C, Guo Q, Cheng W, Shen S, Dong F, Wu A, Li G, Zhu C.   +9 more
europepmc   +1 more source

A new type of glioneuronal tumor: A case report

Interdisciplinary Neurosurgery
Glioneuronal tumors are rare and mostly consist of gangliogliomas. These tumors are usually benign and total resection is usually curative. We report on a new type of tumor in an adolescent with first onset of epilepsy. MRI showed a small contrast-enhancing lesion with minimal perilesional edema.
M.J.F. Landers-Wouters, G.J.M. Rutten, J.W. Kooij, J.M. Kros, H. Ardon   +4 more
openaire   +3 more sources

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source

Monitoring subcutaneous tumors using Mueller polarimetry: study on two types of tumors. [PDF]

Biomed Opt Express, 2021
Varin B, Rehbinder J, Dellinger J, Heinrich C, Torzynski M, Spenlé C, Bagnard D, Zallat J.   +7 more
europepmc   +1 more source

Adaptive Neuro Fuzzy Inference System Used to classify the Five Major Types of Brain Tumors [PDF]

, 2020
Samir Kumar Bandyopadhyay, Shawni Dutta
openalex   +1 more source

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira, Anna Skwarska, Karolina Chwialkowska, Agnieszka Ostrowska, Gabriela Sokolowska, Anna Zeller, Anna Erol, Andrzej Eljaszewicz, Bartosz Hanczaruk, Anna Michalska‐Falkowska, Agnieszka Tarasik, Joanna Reszec‐Gielazyn, Pawel Knapp, Marcin Moniuszko, Adam Kretowski   +14 more
wiley   +1 more source

Immunotherapy in Some Types of Tumors [PDF]

Open Access Journal of Oncology and Medicine, 2018
Charasteristics: Immunotherapy exerts its antitumor action by stimulating the response immune response of patients to cancer, unlike classic treatments, which directly attack the tumor; Previously immunotherapy was limited to patients in whom the conventional treatment, usually with chemotherapy, but currently in patients with some types of tumors ...
openaire   +1 more source

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

Molecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian, Sriraam Sivachandran, Melissa Galati, Brandon Ramchatesingh, Hibo Rijal, Johnny Hanna, Elena Netchiporouk, May Chergui, Margaret Redpath, Samy Abou Setah, Ivan V. Litvinov   +10 more
wiley   +1 more source

Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer

Molecular Oncology, EarlyView.
A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath, Irene A. George, Srikanth S. Manda, Prasanth Ariyannur, Ekta R. Dhawale, Raja Sekhar Kommu, Rajan Datar, Darshana Patil, Vinita Trivedi, Manisha Singh, Kumar Prabhash, Sewanti Limaye, Richa Chauhan, Prashant Kumar   +13 more
wiley   +1 more source

Type 1 Interferon Responses Underlie Tumor-Selective Replication of Oncolytic Measles Virus

, 2020
Sarah Aref, Anna Castleton, Katharine Bailey, Richard Burt, Aditi Dey, Daniel Leongamornlert, Rachel J. Mitchell, Dina Okasha, Adele K. Fielding   +8 more
openalex   +1 more source